2020
DOI: 10.1007/s12265-020-10028-1
|View full text |Cite
|
Sign up to set email alerts
|

Cardiac Imaging in Oncology Patients in Europe: a Model for Advancement of CV Safety and Development of Comprehensive CV Care

Abstract: Cancer therapy-related cardiovascular events are widely recognized as a global problem, and cardio-oncology has been proposed as a new approach to coordinate preventive strategies in oncologic patients. Cardiac imaging plays a critical role in this process. This article summarizes current practices and future needs in cardiac imaging to improve the cardiovascular surveillance of cancer patients. Keywords Cardio-oncology. Cancer. Cardiac imaging. Echocardiography Cancer therapy-related cardiovascular (CV) event… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 36 publications
(36 reference statements)
0
3
0
Order By: Relevance
“…The number of important echocardiographic diagnoses during routine scheduled echocardiographic examinations supports the necessity of performing these examinations regularly and frequently in everyday practice, as recommended by experts ( 10 ). This is the optimal way to plan early prevention ( 25 ). Our data show how important it is to assess cancer patients optimally at baseline and have additional echocardiographic parameters associated with the diastolic function of the left ventricle or function of the left atrium to compare them during active cancer therapy.…”
Section: Discussionmentioning
confidence: 99%
“…The number of important echocardiographic diagnoses during routine scheduled echocardiographic examinations supports the necessity of performing these examinations regularly and frequently in everyday practice, as recommended by experts ( 10 ). This is the optimal way to plan early prevention ( 25 ). Our data show how important it is to assess cancer patients optimally at baseline and have additional echocardiographic parameters associated with the diastolic function of the left ventricle or function of the left atrium to compare them during active cancer therapy.…”
Section: Discussionmentioning
confidence: 99%
“…Evidence from other countries points to the fact that bolstering cancer care services while expanding UHC potentially contributes to general health systems strengthening and broad economic and health gains in the long run [93][94][95]. Investment in human capital and equipment for radiological imaging can further add value to illness detection and treatment, for example in the fields of cardiovascular disease and nutrition [96][97][98]. We remain hopeful that the challenges highlighted in this study can be addressed through concerted action to maximise cancer provisions within the NHI, to establish a national cancer coordinating mechanism to bring together the current fragmented piecemeal approach, such as a NCI, and, finally, to continue to explore the feasibility, desirability and added value of a unified national cancer act.…”
Section: Reflections On Our Study Findingsmentioning
confidence: 99%
“…Different imaging techniques such as magnetic resonance imaging (MRI), positron emission tomography (PET), SPECT (single photon emission tomography), and computed tomography (X -computer tomography) can simultaneously assess antitumor activity and cardiotoxicity evoked by anticancer treatments (55)(56)(57). These imaging techniques allow the early detection and monitoring of a wide range of cardiotoxic events, including systolic and diastolic dysfunction, morphological changes, coronary artery, valve, and pericardial diseases resulting from cancer treatment (56).…”
Section: Ultrasound Techniques To Assess the Antitumor Activity And Cardiotoxicity Of Nanomedicinesmentioning
confidence: 99%